Paradigm Biopharmaceuticals is off to a great start with Managing Director Paul Rennie and Chief Medical Officer Dr Donna Skerrett getting ready to present at the invitation-only 41st JP Morgan Annual Healthcare Meeting in San Francisco, CA. Over 14,000 participants worldwide will attend to share ideas, strategies, and experience to create and apply technologies that will reshape health and wellness.
- Forums
- ASX - By Stock
- PAR
- Annual Healthcare Meeting San Fran Cisco
Annual Healthcare Meeting San Fran Cisco
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 22.5¢ | $186.1K | 801.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 33599 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 65498 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 28599 | 0.230 |
6 | 177453 | 0.225 |
15 | 211076 | 0.220 |
6 | 98958 | 0.215 |
9 | 260864 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 65498 | 1 |
0.240 | 7432 | 3 |
0.245 | 48923 | 2 |
0.250 | 18443 | 2 |
0.260 | 58362 | 1 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online